22157.jpg
Precision Medicine Market Deal Making Trends: "Precision Medicine Collaboration and Licensing Deals (2016-2023)" Comprehensive Report Released
March 18, 2024 05:39 ET | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The realm of precision...
aignostics logo_color14_new.png
Bayer and Aignostics to collaborate on next generation precision oncology
March 14, 2024 03:30 ET | Aignostics GmbH
Not intended for UK Media Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s...
Global gRNA Market
Global gRNA Research Analysis Report 2024: Precision in Gene Editing and Rising Adoption of NGS Technologies Enhancing gRNA Applications
March 13, 2024 11:55 ET | Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global gRNA Market Size, Share & Trends Analysis Report by Product & Services (Products, Custom gRNA Synthesis Services), gRNA Type...
22157.jpg
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023
March 07, 2024 14:59 ET | Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Precision...
SG-Logo.png
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
March 07, 2024 12:07 ET | SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
March 06, 2024 09:15 ET | Cyclacel
BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
Global Generative AI in Personalized Medicine Market
Global Generative AI in Personalized Medicine Market: Projected to Surge at a CAGR of 25.62% Through 2028 - Pharmaceuticals Dominate as AI Accelerates Drug Discovery
February 28, 2024 12:15 ET | Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Generative AI in Personalized Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Kura Oncology Logo
Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024 16:01 ET | Kura Oncology, Inc.
– Positive preliminary combination data from KOMET-007 trial of ziftomenib in NPM1-m and KMT2A-r AML, including effective mitigation of differentiation syndrome – – First patient dosed in KOMET-008...
Global Genomic Cancer Panel and Profiling Market
Genomic Cancer Panel and Profiling Market Set to Reach $26.59 Billion by 2033, Fueled by Advances in Precision Medicine
February 27, 2024 11:44 ET | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application,...
European Gene Fusion Testing Market
Europe Gene Fusion Testing Market Analysis and Forecast Report 2023-2033 Featuring Key Players - Biocartis, F. Hoffmann-La Roche, OncoDNA, and QIAGEN
February 27, 2024 06:33 ET | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Fusion Testing Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe gene fusion...